A comparison of weekly paclitaxel and cetuximab with the EXTREME regimen in the treatment of recurrent/metastatic squamous cell head and neck carcinoma.
Sign Up to like & getrecommendations! Published in 2017 at "Oral oncology"
DOI: 10.1016/j.oraloncology.2017.07.022
Abstract: BACKGROUND The effectiveness of the combination chemotherapy of weekly paclitaxel and cetuximab has not yet been compared to that of the current standard regimen, EXTREME (combination of 5-fluorouracil, cisplatin and cetuximab). METHODS We retrospectively reviewed… read more here.
Keywords: extreme regimen; cetuximab; weekly paclitaxel; cohort ... See more keywords
Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
Sign Up to like & getrecommendations! Published in 2017 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2017.07.135
Abstract: OBJECTIVE To assess whether the addition of oncolytic reovirus (Reolysin®) to weekly paclitaxel prolonged progression-free survival (PFS) in the treatment of women with recurrent or persistent ovarian, tubal or primary peritoneal cancer. PATIENTS AND METHODS… read more here.
Keywords: peritoneal cancer; tubal peritoneal; weekly paclitaxel; ovarian tubal ... See more keywords
Efficacy of weekly paclitaxel for the treatment of advanced ovarian cancer
Sign Up to like & getrecommendations! Published in 2020 at "Medicine"
DOI: 10.1097/md.0000000000020537
Abstract: Abstract Background: This study aims to assess the efficacy and safety of weekly paclitaxel (WP) for the treatment of advanced ovarian cancer (AOC). Methods: This study will systematically search bibliographic databases (MEDLINE, EMBASE, Cochrane Library,… read more here.
Keywords: medicine; paclitaxel treatment; efficacy; treatment ... See more keywords
Investigating the clinical impact of dose-banding for weekly paclitaxel in patients with breast cancer: a retrospective and monocentric study.
Sign Up to like & getrecommendations! Published in 2023 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.15702
Abstract: AIM Dose-Banding (DB) consists in approximating the theoretical dose of anticancer drugs calculated according to the body surface area (Dose-BSA) of patients. This concept is supported by pharmacokinetic but not by clinical data. The aim… read more here.
Keywords: dose bsa; weekly paclitaxel; dose banding; retrospective ... See more keywords
Abstract PS13-39: Efficacy and tolerability of neoadjuvant Pertuzumab, Trastuzumab, and weekly Paclitaxel in Locally advanced Her-2 positive Breast cancer
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs20-ps13-39
Abstract: Background:Administration of neoadjuvant Pertuzumab (P), trastuzumab (T) along with chemotherapy is the standard of care for the management of locally advanced/inflammatory Her-2 positive breast cancer. Neutropenia and diarrhea are often the significant side-effects observed with… read more here.
Keywords: locally advanced; weekly paclitaxel; cancer; breast cancer ... See more keywords
A phase 1b/2 study of napabucasin with weekly paclitaxel in advanced, previously treated non-squamous non-small cell lung cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.9052
Abstract: 9052Background: Napabucasin is a first-in-class cancer stemness inhibitor, identified by its ability to inhibit STAT3-driven gene transcription and spherogenesis of cancer stem cells (Li et al PNAS... read more here.
Keywords: study napabucasin; weekly paclitaxel; paclitaxel advanced; cancer ... See more keywords
A phase 1b study of napabucasin plus weekly paclitaxel in patients with advanced thymoma and thymic carcinoma.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e20001
Abstract: e20001Background: Napabucasin is a first-in-class cancer stemness inhibitor, identified by its ability to inhibit STAT3-driven gene transcription and spherogenesis of cancer stem cells (Li et al PN... read more here.
Keywords: napabucasin plus; study napabucasin; paclitaxel patients; weekly paclitaxel ... See more keywords
Carboplatin plus Weekly Paclitaxel Combined with Bevacizumab as First-line Treatment for Non-small Cell Lung Cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Anticancer research"
DOI: 10.21873/anticanres.11400
Abstract: AIM We aimed to evaluate the efficacy and safety of carboplatin plus weekly paclitaxel with bevacizumab in patients with advanced non-squamous non-small cell lung cancer (NSCLC). PATIENTS AND METHODS Patients with stage IIIB/IV or postoperative… read more here.
Keywords: plus weekly; non small; carboplatin plus; weekly paclitaxel ... See more keywords
Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin
Sign Up to like & getrecommendations! Published in 2021 at "Cancers"
DOI: 10.3390/cancers13040640
Abstract: Simple Summary This study was conducted to evaluate the safety and efficacy of weekly paclitaxel and cisplatin chemotherapy in patients with ovarian cancer who developed carboplatin hypersensitivity reaction. Eighty-six (86) patients who developed hypersensitivity reactions… read more here.
Keywords: chemotherapy; cisplatin; weekly paclitaxel; paclitaxel cisplatin ... See more keywords
Incidence of neuropathy with weekly paclitaxel and role of oral glutamine supplementation for prevention of paclitaxel induced peripheral neuropathy randomized controlled trial
Sign Up to like & getrecommendations! Published in 2018 at "Indian Journal of Medical and Paediatric Oncology"
DOI: 10.4103/ijmpo.ijmpo_38_17
Abstract: Background: Peripheral neuropathy is damage to the peripheral nerve. The most common cause of neuropathy is paclitaxel. Several avenues have been explored to ameliorate the neurotoxicity associated with paclitaxel. Clinical studies have assessed the efficacy… read more here.
Keywords: incidence; paclitaxel induced; grade; peripheral neuropathy ... See more keywords